Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-01-11

Clinical Trial Update: Midodrine in the Recovery Phase of Septic Shock [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of midodrine in the recovery phase of septic shock was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midodrine (Midodrine)

Snippet

Sponsor: University of Virginia | Conditions: Septic Shock | Phase 3 | Status: WITHDRAWN